← Open Payments lookup

JANET DAKERS-BIDLE: Open Payments

NPI 1235368994 · FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$865 in 39 payments from 13 companies in 2025. Trend: 2023 $1,233 · 2024 $950 · 2025 $865

Food & beverage: $865
CompanyPaymentsAmount
Gilead Sciences, Inc.5$139
Ardelyx, Inc.4$120
Takeda Pharmaceuticals U.S.A., Inc.5$108
ABBVIE INC.4$81
Madrigal Pharmaceuticals3$78
Intercept Pharmaceuticals, Inc.3$69
Phathom Pharmaceuticals, Inc.5$66
Regeneron Healthcare Solutions, Inc.3$56
Janssen Biotech, Inc.2$40
Lilly USA, LLC2$39

Products named: IBSRELA, ENTYVIO, REZDIFFRA, OCALIVA, RINVOQ, VOQUEZNA, DUPIXENT, TREMFYA.

Industry payments across MD — which companies pay providers there.